Liminal BioSciences

Liminal BioSciences Inc. is a development-stage biopharmaceutical company based in Laval, Québec, dedicated to the treatment of metabolic, fibrotic, and inflammatory diseases. Utilizing a drug discovery platform combined with a data-driven approach, the company focuses on developing distinctive novel small molecule therapeutics. Their expertise in small molecules has established a robust product pipeline with potential first best-in-class drug candidates. Liminal BioSciences Inc. strives to advance innovative therapies that address unmet medical needs in critical areas of health. Generated from the website

Clementia Pharmaceuticals Inc is a biopharmaceutical company based in St-Mathieu, QC, specializing in the development of novel treatments for rare diseases. The company's focus lies in conducting innovative research and clinical trials to bring potentially life-changing therapies to patients in need. Generated from their business information